BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 6388973)

  • 1. An enzyme-linked immunoassay for detection of IgG- and C3-containing circulating immune complexes: comparison with a radioimmunoassay and quantitation in patients with rheumatic diseases.
    Panush RS; Somberg LB; Katz P; Longley S
    Diagn Immunol; 1983; 1(4):288-94. PubMed ID: 6388973
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Use of solid-phase Clq-ELISA for detecting circulating immune complexes in human diseases].
    Aleshkin VA; Nasonov EL; Eremeeva MV; Kobylianskiĭ AG
    Ter Arkh; 1989; 61(6):113-6. PubMed ID: 2477907
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Determination of circulating immune complexes and of their component immunoglobulin classes M, G, and A with a C1q-ELISA].
    Sequeira Peña GA; Herrmann D; Vogt KH; Jäger L
    Allerg Immunol (Leipz); 1991; 37(1):37-45. PubMed ID: 2063729
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Binding of complement component C5 to model immune complexes and the use of anti-C5 antibodies for determination of C5-containing circulating immune complexes.
    Larsson A; Sjöquist J
    J Clin Lab Immunol; 1989 Jan; 28(1):5-9. PubMed ID: 2724329
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Circulating immune complexes and complement breakdown products in childhood IgA nephropathy].
    Tanaka C; Suhara Y; Kikkawa Y
    Nihon Jinzo Gakkai Shi; 1991 Aug; 33(8):709-17. PubMed ID: 1770631
    [TBL] [Abstract][Full Text] [Related]  

  • 6. C3-containing serum immune complexes in patients with systemic lupus erythematosus: correlation to disease activity and comparison with other rheumatic diseases.
    Huber C; Rüger A; Herrmann M; Krapf F; Kalden JR
    Rheumatol Int; 1989; 9(2):59-64. PubMed ID: 2814209
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Raji cell radioimmune assay for detecting immune complexes in human sera.
    Theofilopoulos AN; Wilson CB; Dixon FJ
    J Clin Invest; 1976 Jan; 57(1):169-82. PubMed ID: 128562
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of C1q-bearing immune complexes by a monoclonal anti-C1q ELISA system.
    Antes U; Heinz HP; Loos M
    J Immunol Methods; 1987 Sep; 102(2):149-56. PubMed ID: 2443573
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Levels of SC5b--9 complement complex in plasma and synovial fluid of patients with rheumatic disease.
    Rus V; Malide D; Boloşiu HD; Parasca I; Duţu AL
    Med Interne; 1990; 28(4):305-10. PubMed ID: 2100875
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Demonstration and analysis of immune complexes in rheumatic diseases].
    Rosenthal M; Graf U; Müller W
    Schweiz Med Wochenschr; 1976 Aug; 106(33):1116-21. PubMed ID: 1087456
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reaction of immune complexes with Hodgkin's disease tissue cultures: radioimmune assay and immunoferritin electron microscopy.
    Long JC; Dvorak AM; Quay SC; Stamatos C; Chi SY
    J Natl Cancer Inst; 1979 Apr; 62(4):787-97. PubMed ID: 372654
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new C1q solid-phase assay for the detection of IgM immune complexes: application to the follow-up of kidney graft recipients with recurrent cytomegalovirus infection.
    Basson J; Tardy JC; Aymard M
    J Clin Lab Immunol; 1990 Jan; 31(1):43-9. PubMed ID: 1966984
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunologic parameters in infective endocarditis: a prospective study.
    Agarwal R; Bahl VK; Malaviya AN; Krishnan S; Chopra P
    Indian Heart J; 1991; 43(3):179-83. PubMed ID: 1800304
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of circulating immune complexes with polyethylene glycol precipitation F(ab')2 anti-C3 ELISA.
    Xu RJ; Gu YA
    J Immunol Methods; 1990 Dec; 135(1-2):225-31. PubMed ID: 2273258
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of an enzyme-linked immunosorbent assay to detect IgG, IgM, and complement (C3) on canine erythrocytes.
    Porter RE; Weiser MG; Callahan GN
    Am J Vet Res; 1989 Aug; 50(8):1365-9. PubMed ID: 2782718
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A method of isolating C1q from human serum and its use in the solid-phase immunoenzyme determination of immune complexes].
    Belozerov AP
    Lab Delo; 1989; (3):24-6. PubMed ID: 2469833
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of a neoantigen on human C3bi and C3d by monoclonal antibody.
    Tamerius JD; Pangburn MK; Müller-Eberhard HJ
    J Immunol; 1985 Sep; 135(3):2015-9. PubMed ID: 2410510
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Presence of fucolipid antigens with mono- and dimeric X determinant (Lex) in the circulating immune complexes of patients with adenocarcinoma.
    Singhal AK; Singhal MC; Nudelman E; Hakomori S; Balint JP; Grant CK; Snyder HW
    Cancer Res; 1987 Nov; 47(21):5566-71. PubMed ID: 2444333
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Binding of complement components C1q, C3, C4 and C5 to a model immune complex in ELISA.
    Larsson A; Sjöquist J
    J Immunol Methods; 1989 Apr; 119(1):103-9. PubMed ID: 2785142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [IgG subclasses in the serum and circulating immune complexes in patients with Kawasaki disease].
    Li CR
    Zhonghua Yi Xue Za Zhi; 1989 Oct; 69(10):578-81, 40. PubMed ID: 2620267
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.